NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
1.650
-0.060 (-3.51%)
At close: Mar 20, 2026, 4:00 PM EDT
1.648
-0.002 (-0.10%)
After-hours: Mar 20, 2026, 6:25 PM EDT
NuCana Market Cap
NuCana has a market cap or net worth of $6.87 million as of March 20, 2026. Its market cap has increased by 90.76% in one year.
Market Cap
6.87M
Enterprise Value
-24.86M
1-Year Change
90.76%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $513.70M to $6.87M, a decrease of -98.66%. That is a compound annual growth rate of -39.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 7.10M | -52.67% |
| Dec 31, 2025 | 15.00M | 219.15% |
| Dec 31, 2024 | 4.70M | -69.87% |
| Dec 29, 2023 | 15.60M | -54.65% |
| Dec 30, 2022 | 34.40M | -72.30% |
| Dec 31, 2021 | 124.20M | -21.19% |
| Dec 31, 2020 | 157.60M | -19.84% |
| Dec 31, 2019 | 196.60M | -57.38% |
| Dec 31, 2018 | 461.30M | 43.44% |
| Dec 29, 2017 | 321.60M | -37.40% |
| Sep 28, 2017 | 513.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Matinas BioPharma Holdings | 3.84M |
| GRI Bio | 3.73M |
| Purple Biotech | 3.39M |
| Aspire Biopharma Holdings | 3.35M |
| Galmed Pharmaceuticals | 3.26M |
| XORTX Therapeutics | 3.25M |
| Oragenics | 3.23M |
| Azitra | 2.87M |